Condition
Blunt Injury
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Withdrawn1
Completed1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07012863Phase 4Not Yet Recruiting
Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting
NCT04588311Phase 3Recruiting
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
NCT02440373Completed
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome
NCT01852773WithdrawnPrimary
Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury
Showing all 4 trials